alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 35.2

SERVICER COMPLIANCE STATEMENT

In connection with the Annual Report on Form 10-K of Santander Drive Auto Receivables Trust 2015-4 for the fiscal year ended December 31, 2017 (the Report), the undersigned, a duly authorized officer of Santander Consumer International Puerto Rico LLC (the Subservicer), does
hereby certify and represent that:



| | 1. | A review of the activities and performance of the Subservicer under the Sale and Servicing Agreement, dated as of August 26, 2015, among Santander Drive Auto Receivables LLC, Santander Consumer USA Inc., Santander
Drive Auto Receivables Trust 2015-4 and Wells Fargo Bank, National Association (the Agreement) during the period that is the subject of the Report has been made under my supervision.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | A review of the activities and performance of the Subservicer under the Servicing Agreement, dated July 15, 2016 (the Servicing Agreement), by and between Santander Consumer USA Inc. and Santander
Consumer International Puerto Rico LLC, and the related Second Amended and Restated Program Portfolio Schedule (Publicly Registered Transactions), dated as of June 28, 2017 (the Second Amended and Restated Program Portfolio Schedule, together
with the Servicing Agreement, the Subservicing Agreement), during the period that is the subject of the Report has been made under my supervision.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 3. | To the best of my knowledge, based on such review, the Subservicer has fulfilled all of its obligations under the Agreement and the Subservicing Agreement in all material respects throughout the period that is the
subject of the Report.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



SANTANDER CONSUMER INTERNATIONAL PUERTO RICO LLCBy:

/s/ Jose RamirezName:

Jose RamirezTitle:

Vice President of Servicing for Santander Consumer International Puerto Rico, LLCDate:

March 30, 2018
[Federal Register Volume 75, Number 42 (Thursday, March 4, 2010)]
[Notices]
[Page 9910]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4480]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Mechanisms of Acclimatization 
(Perinatology).
    Date: April 1, 2010.
    Time: 1 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6100 Executive Boulevard, 
Room 5B01, Bethesda, MD 20892. (Telephone Conference Call)
    Contact Person: Rita Anand, PhD, Scientific Review Officer, 
Division of Scientific Review, Eunice Kennedy Shriver National 
Institute, of Child Health and Human Development, NIH, 6100 
Executive Blvd. Room 5B01, Bethesda, MD 20892, (301) 496-1487, 
<a href="/cdn-cgi/l/email-protection#7d1c131c13190f3d101c141153131415531a120b"><span class="__cf_email__" data-cfemail="0d6c636c63697f4d606c646123636465236a627b">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: February 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-4480 Filed 3-3-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.2340 Electrocardiograph. ( a ) *Identification.* An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.6175 Cardiopulmonary emergency cart. ( a ) *Identification.* A cardiopulmonary emergency cart is a device intended to store and transport resuscitation supplies for emergency treatment. The device does not include any equipment used in cardiopulmonary resuscitation.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 868.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[47 FR 31142, July 16, 1982, as amended at 54 FR 25048, June 12, 1989; 66 FR 38796, July 25, 2001]
#### § 610.67 Bar code label requirements.

Biological products must comply with the bar code requirements at § 201.25 of this chapter. However, the bar code requirements do not apply to devices regulated by the Center for Biologics Evaluation and Research or to blood and blood components intended for transfusion. For blood and blood components intended for transfusion, the requirements at § 606.121(c)(13) of this chapter apply instead.

[69 FR 9171, Feb. 26, 2004]
<PAGE>

                                                                    EXHIBIT 31.2

                                  CERTIFICATION

I, Francis H. Murphy, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of Biopure Corporation;

2.    Based on my knowledge, this report does not contain any untrue statement
      of a material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      report;

3.    Based on my knowledge, the financial statements, and other financial
      information included in this report, fairly present in all material
      respects the financial condition, results of operations and cash flows of
      the registrant as of, and for, the periods presented in this report;

4.    The registrant's other certifying officer(s) and I are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a- 15(e) and 15d-15(e)) for the registrant
      and have:

      (a) Designed such disclosure controls and procedures, or caused such
      disclosure controls and procedures to be designed under our supervision,
      to ensure that material information relating to the registrant, including
      its consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this report is being
      prepared;

      (b) Evaluated the effectiveness of the registrant's disclosure controls
      and procedures and presented in this report our conclusions about the
      effectiveness of the disclosure controls and procedures, as of the end of
      the period covered by this report based on such evaluation; and

      (c) Disclosed in this report any change in the registrant's internal
      control over financial reporting that occurred during the registrant's
      most recent fiscal quarter (the registrant's fourth fiscal quarter in the
      case of an annual report) that has materially affected, or is reasonably
      likely to materially affect, the registrant's internal control over
      financial reporting; and

5.    The registrant's other certifying officer(s) and I have disclosed, based
      on our most recent evaluation of internal control over financial
      reporting, to the registrant's auditors and the audit committee of the
      registrant's board of directors (or persons performing the equivalent
      functions):

      (a) All significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the registrant's ability to record,
      process, summarize and report financial information; and

      (b) Any fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant's internal control
      over financial reporting.

Date: June 9, 2005

/s/ Francis H, Murphy
----------------------
Francis H. Murphy
Chief Financial Officer
§ 876.5900 Ostomy pouch and accessories. ( a ) *Identification.* An ostomy pouch and accessories is a device that consists of a bag that is attached to the patient's skin by an adhesive material and that is intended for use as a receptacle for collection of fecal material or urine following an ileostomy, colostomy, or ureterostomy (a surgically created opening of the small intestine, large intestine, or the ureter on the surface of the body). This generic type of device and its accessories includes the ostomy pouch, ostomy adhesive, the disposable colostomy appliance, ostomy collector, colostomy pouch, urinary ileostomy bag, urine collecting ureterostomy bag, ostomy drainage bag with adhesive, stomal bag, ostomy protector, and the ostomy size selector, but excludes ostomy pouches which incorporate arsenic-containing compounds.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
[48 FR 53023, Nov. 23, 1983, as amended at 54 FR 25050, June 12, 1989; 66 FR 38802, July 25, 2001]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Environmental Protection Agency

          - [FRL-9121-7]

# AGENCY:

Environmental Protection Agency (EPA).

# ACTION:

Notice of Charter Renewal

                    The Charter for the Environmental Protection Agency's Farm, Ranch, and Rural Communities Advisory Committee (FRRCC) will be renewed for an additional two-year period, as a necessary committee which is in the public interest, in accordance with the provisions of the Federal Advisory Committee Act (FACA), 5 U.S.C. App.2. The purpose of the FRRCC is to provide advice to the Administrator of EPA on environmental issues and policies that are of importance to agriculture and rural communities. It is determined that the FRRCC is in the public interest in connection with the performance of duties imposed on the Agency by law. Inquiries may be directed to Alicia Kaiser, U.S. EPA, (mail code 1101-A), 1200 Pennsylvania Avenue, NW., Washington, DC 20460, telephone (202) 564-7273, or                     *kaiser.alicia@epa.gov.*

Dated: February 18, 2010.

Lawrence Elworth,

Agricultural Counselor to the Administrator.

[FR Doc. 2010-4549 Filed 3-3-10; 8:45 am]

BILLING CODE 6560-50-P
§ 582.3221 Calcium propionate. ( a ) *Product.* Calcium propionate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.4725 Radiofrequency lesion probe. ( a ) *Identification.* A radiofrequency lesion probe is a device connected to a radiofrequency (RF) lesion generator to deliver the RF energy to the site within the nervous system where a lesion is desired.
( b ) *Classification.* Class II (performance standards).
EXHIBIT 1

NEWS RELEASE

COMC, INC.
2840 Howe Road, Suite D
Martinez, CA 94553

January 11, 2001
For Immediate Release

Contact: Christopher R. Smith (925) 335-4000 Chief Executive Officer, President
         & Chief Financial Officer


COMC, INC. COMPLETES DELAWARE REINCORPORATION

SAN FRANCISCO, CA (January 11, 2001) - COMC, INC. (OTC-CINJ.OB) announced that
today it had completed the process to reincorporate COMC as a Delaware
corporation. The reincorporation, which was approved by more than two-thirds of
COMC's shareholders at COMC's annual meeting in November, has a number of
advantages for COMC: the Delaware legislature is responsive to business needs of
corporations and acts quickly to enact relevant new laws; Delaware has extensive
case law on corporate issues, thereby providing corporations with more certainty
about the application of laws in specific circumstances; Delaware state courts
that specialize in corporate law have developed an expertise in dealing with
corporate issues; and Delaware has developed a sharper definition of director
responsibilities so that boards may act with greater certainty on issues
affecting shareholders. COMC is the parent company of ICF Communication
Solutions, Inc., and is a technology service company in the telecommunications
industry with a rapidly expanding national geographic service coverage area.
Through its wholly owned subsidiary ICF, COMC designs, implements, supports and
manages LAN/WAN computer network systems, voice communication network systems
and premise wiring for both data and voice. COMC's common stock is currently
included for quotation on the OTC Bulletin Board under the symbol CINJ.OB.
<PAGE>

                                                                    EXHIBIT 32.1

                                  CERTIFICATION
                           PURSUANT TO 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      I, Richard M. Feldt, Chief Executive Officer of Evergreen Solar, Inc.,
certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of Evergreen
Solar, Inc. for the fiscal year ended December 31, 2005 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that information contained in such Annual Report on Form 10-K fairly
presents, in all material respects, the financial condition and results of
operations of Evergreen Solar, Inc.

Date: March 16, 2006                         /s/ Richard M. Feldt
                              --------------------------------------------------
                                               Richard M. Feldt
                                    Chief Executive Officer and President

      A signed original of this written statement required by Section 906 has
been provided to Evergreen Solar, Inc. and will be retained by Evergreen Solar,
Inc. and furnished to the Securities and Exchange Commission or its staff upon
request.
Exhibit 15

                           Accountants' Acknowledgment

Footstar, Inc.
Mahwah, New Jersey

Board of Directors:

Re:  Registration Statements Numbers 33-20731, 33-30011 and 33-41390 on Form S-8

With respect to the subject registration statements, we acknowledge our
awareness of the use therein of our report dated October 20, 2000 related to our
review of interim financial information.

Pursuant to Rule 436(c) under the Securities Act of 1933, such report is not
considered a part of a registration statement prepared or certified by an
accountant or a report prepared or certified by an accountant within the meaning
of sections 7 and 11 of the Act.



                                                     /s/KPMG LLP

Short Hills, New Jersey
November 14,  2000


                                       23
| (logo) Prudential | Prudential Asset Resources, Inc.

 

Prudential Mortgage Capital Company

2100 Ross Avenue, Suite 2500 Dallas, TX 75201

Tel 877-937-4500 |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------|

 

Wells Fargo Commercial Mortgage Securities, Inc.

c/o Wells Fargo Securities, LLC

375 Park Avenue, 2nd Floor

J0127-023, New York, New York 10152-023

Attention: AJ Sfarra

 

RE:**WFCM 2015-SG1**

Period**: August 1, 2015 to December 31, 2015 (the "Reporting Period")**

 

Annual Compliance Statement

 

 

I, Timothy E. Steward, in my capacity as President and Managing Director of Prudential Asset Resources, Inc. (the "Company") hereby certify with regard to the Company's role as Primary Servicer under the Pooling and Servicing Agreement, (the "Agreement") dated as of August 1, 2015 pertaining to the above-referenced certificates, that:

 

(i) a review of the activities of the Company under the Agreement during the period noted above, and of the performance of the Company under the Agreement during the reporting period has been made under my supervision, and

 

(ii) to the best of my knowledge, based on such review, the Company has fulfilled all its obligations under the Agreement throughout the reporting period.

 

Effective as of 2/24/2016

 

 

/s/ Timothy E. Steward

Timothy E. Steward

President and Managing Director

Prudential Asset Resources, Inc.
Michigan Supreme Court

Lansing, Michigan

Marilyn Kelly,

 Chief Justice

Michael F. Cavanagh

Elizabeth A. Weaver

Maura D. Corrigan

Robert P. Young, Jr.

Stephen J. Markman

Diane M. Hathaway, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

June 28, 2010 

p0621 

Order 

 

June 28, 2010 

140669 & (71) 

 

In re ELMER M. DOBSON TRUST. 

_________________________________________/ 

DANIEL W. DOBSON and STEVEN M. DOBSON, 

Petitioners-Appellees, 

v SC: 140669 

 COA: 285248 

Branch PC: 06-032131-TV 

SOUTHERN MICHIGAN BANK & TRUST, 

Respondent-Appellee, 

and 

AUTUMN L. IVEY and CHARITY IVEY 

TAYLOR, 

 Respondents-Appellants. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the January 19, 2010 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court. The motion for 

sanctions is DENIED.
QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.1    
  


NOT
VALID UNLESS COUNTERSIGNED BY TRANSFER AGENT

INCORPORATED UNDER THE LAWS OF THE STATE OF
 Nevada



	NUMBER	 	 	 	 	 	 	 	SHARES
	*XXX*	 	[VITALSTREAMTM HODLINGS, INC. LOGO]	 	[*XXX*]

Cusip No. 92847T 10
	AUTHORIZED COMMON STOCK 290,000,000 SHARES

PAR VALUE: $.001
	

THIS CERTIFIES THAT	
 	

[XXXXX XXXXXX]	
 	

 	
 	

 
	
IS THE RECORD HOLDER OF	
 	

[Xxx Xxxxx Xxxxxx]	
 	

 	
 	

 
	

Shares of VITALSTREAM HOLDINGS, INC. Common Stock
	

transferable on the books of the Corporation in person or by duly authorized attorney upon surrender of this Certificate properly endorsed.

This Certificate is not valid until countersigned by the Transfer Agent and registered by the Registrar.
	
Witness the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers.
	

Dated: [XXXXXX]	
 	

 	
 	

 	
 	

 
	

	
 	

 	
 	


	Secretary	 	 	 	PRESIDENT
	

PROGRESSIVE TRANSFER COMPANY P.O. BOX 17561 / SALT LAKE CITY, UTAH 84117	
 	

 
	 	 	 	 	 	 	COUNTERSIGNED & REGISTERED
	COUNTERSIGNED Transfer Agent—Authorized Signature











QuickLinks



Exhibit 4.1
Exhibit 31.3



AMENDMENT NO. 1

STATEMENT OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a  14(a)/15d  14(a)



I, Martin L. Vaughan, III, Chairman and Chief Executive Officer of Hilb Rogal &
Hobbs Company, certify that:



1. I have reviewed this report
on Form 10-Q/A (Amendment No. 1) of Hilb Rogal & Hobbs Company; and



2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report.



|                      |  |                                     
|--------------------- |  | ------------------------------------
|Date January 11, 2006 |  | /s/ Martin L. Vaughan, III          
|                      |  | Martin L. Vaughan, III              
|                      |  | Chairman and Chief Executive Officer